Omalizumab is not just an anti-immunoglobulin E.

Goknur O Yavuz Ibrahim Halil Yavuz Huseyin Serhat Inaloz Cagdas Boyvadoglu

Published in: The Journal of dermatological treatment (2022)

This study shows that omalizumab can affect mast cells other than IgE. To the best of our knowledge, this is the first study to show the relationship between omalizumab and VIP.

Keyphrases

healthcare